Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold

BACKGROUND: Early studies evaluating the performance of bioresorbable scaffold (BRS) Absorb in in-stent restenosis (ISR) lesions indicated promising short-term to mid-term outcomes. AIMS: To evaluate long-term outcomes (up to 5 years) of patients with ISR treated with the Absorb BRS. METHODS: We did...

Descripción completa

Detalles Bibliográficos
Autores principales: Madanchi, Mehdi, Cioffi, Giacomo Maria, Attinger-Toller, Adrian, Wolfrum, Mathias, Moccetti, Federico, Seiler, Thomas, Vercelli, Luca, Burkart, Philipp, Toggweiler, Stefan, Kobza, Richard, Bossard, Matthias, Cuculi, Florim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438862/
https://www.ncbi.nlm.nih.gov/pubmed/34518287
http://dx.doi.org/10.1136/openhrt-2021-001776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438862/
https://www.ncbi.nlm.nih.gov/pubmed/34518287
http://dx.doi.org/10.1136/openhrt-2021-001776

Ejemplares similares